195 related articles for article (PubMed ID: 26460696)
1. The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
Int J Oncol; 2015 Dec; 47(6):2057-63. PubMed ID: 26460696
[TBL] [Abstract][Full Text] [Related]
2. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
[TBL] [Abstract][Full Text] [Related]
3. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis.
Takahashi Y; Koyanagi T; Suzuki Y; Saga Y; Kanomata N; Moriya T; Suzuki M; Sato Y
Mol Cancer Res; 2012 Sep; 10(9):1135-46. PubMed ID: 22826464
[TBL] [Abstract][Full Text] [Related]
4. Vasohibin-1 inhibits angiogenesis and suppresses tumor growth in renal cell carcinoma.
Zhao G; Na R; Li L; Xiao H; Ding N; Sun Y; Han R
Oncol Rep; 2017 Aug; 38(2):1021-1028. PubMed ID: 28656230
[TBL] [Abstract][Full Text] [Related]
5. Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by
Huang B; Huang M; Li Q
Technol Cancer Res Treat; 2019; 18():1533033819879905. PubMed ID: 31757187
[TBL] [Abstract][Full Text] [Related]
6. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
7. Vasohibin-1 suppresses colon cancer.
Liu S; Han B; Zhang Q; Dou J; Wang F; Lin W; Sun Y; Peng G
Oncotarget; 2015 Apr; 6(10):7880-98. PubMed ID: 25797264
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
9. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.
Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M
Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025
[TBL] [Abstract][Full Text] [Related]
10. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice.
Pourgholami MH; Yan Cai Z; Lu Y; Wang L; Morris DL
Clin Cancer Res; 2006 Mar; 12(6):1928-35. PubMed ID: 16551879
[TBL] [Abstract][Full Text] [Related]
11. Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma.
Sano R; Kanomata N; Suzuki S; Shimoya K; Sato Y; Moriya T; Shiota M
Tohoku J Exp Med; 2017 Oct; 243(2):107-114. PubMed ID: 29057763
[TBL] [Abstract][Full Text] [Related]
12. A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans.
Watanabe T; Okada Y; Hoshikawa Y; Eba S; Notsuda H; Watanabe Y; Ohishi H; Sato Y; Kondo T
Transplant Proc; 2012 May; 44(4):1155-7. PubMed ID: 22564651
[TBL] [Abstract][Full Text] [Related]
13. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment.
Koyanagi T; Suzuki Y; Komori K; Saga Y; Matsubara S; Fujiwara H; Sato Y
Cancer Sci; 2017 Mar; 108(3):512-519. PubMed ID: 28032401
[TBL] [Abstract][Full Text] [Related]
14. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
Li Y; Xiao M; Guo F
Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
[TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
[TBL] [Abstract][Full Text] [Related]
17. Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo.
Kern J; Steurer M; Gastl G; Gunsilius E; Untergasser G
BMC Cancer; 2009 Aug; 9():284. PubMed ID: 19682397
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion.
Nonaka H; Saga Y; Fujiwara H; Akimoto H; Yamada A; Kagawa S; Takei Y; Machida S; Takikawa O; Suzuki M
Int J Oncol; 2011 Jan; 38(1):113-20. PubMed ID: 21109932
[TBL] [Abstract][Full Text] [Related]
19. The vasohibin family: Novel regulators of angiogenesis.
Sato Y
Vascul Pharmacol; 2012; 56(5-6):262-6. PubMed ID: 22286022
[TBL] [Abstract][Full Text] [Related]
20. Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion.
Suzuki Y; Kobayashi M; Miyashita H; Ohta H; Sonoda H; Sato Y
J Cell Sci; 2010 Sep; 123(Pt 18):3094-101. PubMed ID: 20736312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]